Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.
作者信息
Elliott R W, Essenhigh D M, Morley A R
出版信息
Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1160-1. doi: 10.1136/bmj.284.6323.1160.
Abstract
摘要
相似文献
1
Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.环磷酰胺治疗系统性红斑狼疮：膀胱癌风险超过益处。
Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1160-1. doi: 10.1136/bmj.284.6323.1160.
2
Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.接受环磷酰胺治疗系统性红斑狼疮或类风湿关节炎患者的膀胱并发症。
Ann Intern Med. 1979 Aug;91(2):221-3. doi: 10.7326/0003-4819-91-2-221.
3
Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.环磷酰胺治疗系统性红斑狼疮：膀胱癌风险超过益处。
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1710-1. doi: 10.1136/bmj.284.6330.1710-d.
4
Bladder cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide.一名患有系统性红斑狼疮的年轻女孩接受环磷酰胺治疗后发生膀胱癌。
Acta Urol Belg. 1991;59(1):133-7.
5
Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion.在摄入环磷酰胺15年后膀胱同时发生移行细胞癌、鳞状细胞癌和腺癌。
J Urol. 1981 Mar;125(3):424-6. doi: 10.1016/s0022-5347(17)55061-2.
6
Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.环磷酰胺诱发狼疮性肾炎患者的膀胱移行细胞癌
Intern Med J. 2002 Mar;32(3):114-6.
7
Bladder cancer after cyclophosphamide therapy for lupus nephritis.环磷酰胺治疗狼疮性肾炎后发生的膀胱癌。
Nephron. 1992;60(3):378-9. doi: 10.1159/000186790.
8
Azathioprine and urinary bladder tumor.硫唑嘌呤与膀胱肿瘤
Ann Intern Med. 1983 Nov;99(5):737. doi: 10.7326/0003-4819-99-5-737_1.
9
Uroepithelial carcinoma in association with cyclophosphamide ingestion.与环磷酰胺摄入相关的尿路上皮癌。
J Urol. 1981 Oct;126(4):544-5. doi: 10.1016/s0022-5347(17)54619-4.
10
[Urothelial carcinoma of the bladder following cyclophosphamide therapy].环磷酰胺治疗后发生的膀胱尿路上皮癌
Z Urol Nephrol. 1984 Jan;77(1):7-9.
引用本文的文献
1
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.加利福尼亚州系统性红斑狼疮（SLE）患者队列中的癌症风险。
Cancer Causes Control. 2008 Oct;19(8):887-94. doi: 10.1007/s10552-008-9151-8. Epub 2008 Apr 2.
2
Malignancy and systemic lupus erythematosus.恶性肿瘤与系统性红斑狼疮
Curr Rheumatol Rep. 2002 Aug;4(4):351-8. doi: 10.1007/s11926-002-0045-6.
3
Drug-induced bladder and urinary disorders. Incidence, prevention and management.药物性膀胱和泌尿系统疾病。发病率、预防与管理。
Drug Saf. 1998 Jul;19(1):45-55. doi: 10.2165/00002018-199819010-00004.
4
Apheresis therapy: spin-drying the blood.血液成分单采治疗：血液离心干燥。
Br Med J (Clin Res Ed). 1982 Oct 23;285(6349):1136-7. doi: 10.1136/bmj.285.6349.1136.
5
Bladder carcinoma following cyclophosphamide therapy. A case report.环磷酰胺治疗后发生的膀胱癌。病例报告。
Int Urol Nephrol. 1985;17(2):139-42. doi: 10.1007/BF02082484.
6
Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide.环磷酰胺治疗后卵巢肿瘤和乳腺癌患者患白血病的风险。
Br J Cancer. 1987 Feb;55(2):213-8. doi: 10.1038/bjc.1987.40.
7
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.
8
The treatment of lupus nephritis.狼疮性肾炎的治疗。
Pediatr Nephrol. 1989 Jul;3(3):350-62. doi: 10.1007/BF00858546.
本文引用的文献
1
Carcinoma of the urinary bladder in patients receiving cyclophosphamide.接受环磷酰胺治疗的患者发生的膀胱癌
N Engl J Med. 1975 Aug 7;293(6):271-3. doi: 10.1056/NEJM197508072930604.
2
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.英国和澳大利亚关于接受免疫抑制药物治疗患者癌症的联合研究。
Br Med J. 1979 Dec 8;2(6203):1461-6. doi: 10.1136/bmj.2.6203.1461.
Zotero 插件